4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-002048
Director bought 200,000 shares at $21.00 ($4,200,000)
- Director acquired 5,826,832 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Jovan-Embiricos Morana · Director
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-12 | Conversion : show line 1 in the form | +1,136,525 | 1,136,525 | I | ||
| 2021-01-12 | Conversion : show line 2 in the form | +2,912,345 | 2,912,345 | I | ||
| 2021-01-12 | Conversion : show line 3 in the form | +639,295 | 639,295 | I | ||
| 2021-01-12 | Conversion : show line 4 in the form | +455,338 | 455,338 | I | ||
| 2021-01-12 | Conversion : show line 5 in the form | +182,135 | 182,135 | I | ||
| 2021-01-12 | Conversion : show line 6 in the form | +71,599 | 526,937 | I | ||
| 2021-01-12 | Conversion : show line 7 in the form | +143,198 | 325,333 | I | ||
| 2021-01-12 | Conversion : show line 8 in the form | +71,599 | 71,599 | I | ||
| Open-market purchases · 200,000 sh · avg $21.00 · $4,200,000 | ||||||
Table II: Derivative
9 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-12 | Conversion : show line 12 in the form Series Seed Convertible Preferred Stock | −8,000,000 | 0 | I |
| 2021-01-12 | Conversion : show line 13 in the form Series A Convertible Preferred Stock | −20,500,000 | 0 | I |
| 2021-01-12 | Conversion : show line 14 in the form Series A Convertible Preferred Stock | −4,500,000 | 0 | I |
| 2021-01-12 | Conversion : show line 15 in the form Series B Convertible Preferred Stock | −3,205,128 | 0 | I |
| 2021-01-12 | Conversion : show line 16 in the form Series B Convertible Preferred Stock | −1,282,051 | 0 | I |
| 2021-01-12 | Conversion : show line 17 in the form Series C Convertible Preferred Stock | −503,988 | 0 | I |
| 2021-01-12 | Conversion : show line 18 in the form Series C Convertible Preferred Stock | −1,007,977 | 0 | I |
| 2021-01-12 | Conversion : show line 19 in the form Series C Convertible Preferred Stock | −503,988 | 0 | I |
| 2021-01-12 | Conversion : show line 20 in the form Series C Convertible Preferred Stock | −1,511,966 | 0 | I |
Loading xslF345X03/doc4.xml…